Hypertrophic cardiomyopathy (HCM) is the most common cardiac genetic disorder and is characterized by left ventricular hypertrophy (LVH), myocyte, disarray, and fibrosis. Other causes of LVH such as hypertension, storage diseases, and athletes should be excluded. Variations in pattern of hypertrophy, systolic anterior motion of the mitral valve, and left ventricular outflow tract (LVOT) obstruction are commonly seen, even in patients carrying the same mutation. A significant proportion of patients diagnosed as having HCM develop arrhythmias, chest pain, and/or heart failure symptoms requiring interventions such as defibrillator implantation and myectomy/alcohol septal ablation. [1] [2] [3] Exercise stress testing is widely used to evaluate patients with HCM. Exercise echocardiography is used for diagnosing patients with labile obstruction, who despite of absence of LVOT obstruction at rest have significant LVOT obstruction at exercise 4 and therefore need intensive medical therapy or even septal reduction procedures. 5 Standard exercise testing helps assess the risk for sudden cardiac death (SCD) and permits an objective assessment of functional capacity. 6, 7 Furthermore, it helps in providing patients with a tailored exercise regimen and can provide information on autonomic function in HCM. 8 Although exercise has been shown to ameliorate hypertrophy in mouse models of HCM, it can also serve as a trigger for ventricular arrhythmias and sudden death. 6, 9 Hence, in clinical practice, HCM patients with high LVOT pressure gradients, for example, N30 mm Hg, are often excluded from exercise testing because of safety considerations and controversy about the usefulness of the test in this group of patients. 4, 10 In the recent American College of Cardiology/American Heart Association guidelines, stress testing has IIA recommendations under the following circumstances: (1) "Treadmill exercise testing is reasonable to determine functional capacity and response to therapy in patients with HCM." (2) "Treadmill testing with monitoring of an ECG and blood pressure is reasonable for SCD risk stratification in patients with HCM." (3) "In patients with HCM who do not have a resting LVOT instantaneous gradient of greater than or equal to 50 mm Hg, exercise echocardiography is reasonable for the detection and quantification of exercise-induced dynamic LVOT obstruction." However, current guidelines provide little guidance in patients with gradients N50 mm Hg.
11
In this study, we report the utility, safety, and clinical profile of 499 consecutive patients with HCM undergoing 959 treadmill exercise tests.
Methods

Study population
This study was approved by the Johns Hopkins institutional review board. We enrolled 499 consecutive patients with HCM referred for treadmill stress at the Johns Hopkins HCM clinic in the period from February 2005 to October 2013. All patients fulfilled the criteria for a diagnosis of HCM defined as unexplained hypertrophy with a maximal wall thickness above 15 mm in the absence of other cardiac or systemic conditions capable of producing a similar degree of LVH. Patients with a maximal wall thickness of 13 to 15 mm were diagnosed as having HCM in case of other features suggestive of HCM such as systolic anterior motion, elevated LVOT gradients, family history of HCM, or positive genetic test result. 11 Information about medical history and use of medication was collected during the initial visit in the HCM clinic. The cohort was separated according to recent guidelines into a nonobstructive group (resting peak LVOT gradient b30 mm Hg and exercise peak LVOT gradient b30 mm Hg), a labile-obstructive group (resting peak LVOT gradient b30 mm Hg and exercise peak LVOT gradient ≥30 mm Hg), and an obstructive group (resting peak LVOT gradient ≥30 mm Hg). 11 When evaluating baseline characteristics, clinical response to exercise, and utility of exercise testing, we used the initial test of the 499 patients; however, when investigating the safety profile, we used all the exercise tests of the 499 patients performed in the full study period (n = 959).
Resting electrocardiogram
The electrocardiograms (ECGs) were analyzed according to the European Society of Cardiology guidelines. 12 Patients with QRS width ≥120 milliseconds were considered having bundle-branch block and divided according to configuration into left bundle-branch block (LBBB) and right bundle-branch block. Cardiac repolarization was carefully analyzed in patients without bundle-branch block, ST depression was defined as ST-segment depression of at least ≥1 mm in 2 contiguous leads, and T-wave inversion was defined as T-wave inversion ≥1 mm in at least 2 contiguous leads.
Treadmill exercise test
All patients in our HCM clinic routinely undergo treadmill exercise testing at every visit unless excluded per the following conditions listed below: unable to walk on the treadmill, blood pressure (BP) N220/120 mm Hg, unstable angina, recent myocardial infarction (b1 week), decompensated heart failure, and active atrial arrhythmia (resting heart rate [HR] N120 beats/min).
A standard Bruce protocol is implemented unless patients reported very low exercise tolerance, in which case a modified Bruce or Naughton protocol was used. Patients had continuous 12-lead ECG monitoring, and BP was measured at each stage. Patients were encouraged to exercise until development of symptoms limiting continuation of exercise or inability to exercise further. The test was terminated early in case of sustained ventricular arrhythmia, symptomatic drop in BP, ST elevation, or development of severe symptoms. Ongoing medications were continued before stress testing.
Data regarding exercise-induced symptoms, exercise capacity, ECG changes, abnormal blood pressure response (ABPR), and arrhythmias were collected. Symptoms monitored were chest pain, dyspnea, and syncope. Exercise capacity was expressed as metabolic equivalents (METs) and percentage of HR achieved. Significant ECG changes from baseline were defined according to American College of Cardiology guidelines as either horizontal or downsloping ST depression or ST elevation (N1 mm in 2 corresponding leads 80 milliseconds from the J point).
13 Nonspecific ST-T changes were defined as any ST-T changes not fulfilling the above criteria. Patients with active pacemakers (n = 22), LBBB (n = 15), and resting ST depressions (n = 76) not allowing analysis of ST-T changes were excluded from ECG analysis (n = 113). Abnormal blood pressure response was defined as follows: (1) blunted BP response, b20 mm Hg increase of systolic BP, or (2) hypotensive response, N20 mm Hg decrease of systolic BP from baseline BP or an initial rise in systolic BP followed by a decrease of systolic BP N20 mm Hg. 7, 14 Arrhythmias were registered as supraventricular tachycardia (SVT), nonsustained ventricular tachycardia (NSVT; duration b30 seconds), sustained ventricular arrhythmia (duration N30 seconds), and ventricular fibrillation (VF)/pulseless ventricular tachycardia (VT). The complication rate during exercise testing was evaluated as number of arrhythmias but also the combined safety end point, which was defined as syncope or onset of any arrhythmia.
Echocardiography
A Vivid 7 cardiac ultrasound machine (GE Healthcare, Milwaukee, WI) with a 3.5-MHz transducer was used. Echocardiographic examinations were performed with the patient in the left lateral decubitus position. 15 The following parameters were obtained and measured according to the recommendations of American Society of Echocardiography: end-diastolic and end-systolic left ventricular (LV) dimensions at the level of the mitral leaflets tips in the parasternal long-axis view; LV ejection fraction was calculated from these LV dimensions using the Teichholz formula. Maximal wall thickness was measured in the parasternal long-axis view, short-axis view, or 4-chamber image with focus on the apex. 16 Peak LVOT gradients were measured in the apical long-axis and 5-chamber view at rest and immediately (usually within 30 seconds) after exercise using continuous wave Doppler technique. 17 left ventricular outflow tract gradients were also calculated from the mitral regurgitation (MR) jet measured during rest and after exercise with the following formula: LVOT gradient = MR gradient − systolic BP + left atrial pressure (estimated 10 mm Hg). 18 
Statistics
All continuous data were summarized as mean and SD. Categorical data were summarized as frequency and percentage with 95% CI. Analysis of variance (ANOVA) was used to compare continuous variables among the 3 groups, and intergroup differences were calculated with Student t test. χ 2 Test was used to compare categorical data; in case of low number of events (n b 5), Fisher exact test was used. A P value of b.05 was considered significant. Multivariate analysis was done with regard to METs. Statistical analysis was performed with Stata/IC 12.1 statistical software (StataCorp, College Station, TX).
Results
We enrolled 499 consecutive patients with HCM at their initial evaluation with exercise testing at our HCM clinic; all patients fulfilled our inclusion criteria. Baseline clinical and echocardiographic characteristics at the initial exercise test are presented in Tables I and II. Nineteen patients (3.8%) had atrial fibrillation, and 14 patients (3%) had a history of septal reduction procedures; 9 had myectomy and 5 had alcohol ablation. Family history of HCM and implantable cardioverter-defibrillator (ICD) were more common in the nonobstructive group. However, history of coronary disease and hypertension and the use of medications were the same in all groups. Likewise, resting ECG changes were similar in the 3 groups.
The 499 patients underwent a total of 959 treadmill tests: 286 patients (57%) had 1 test, 99 patients (20%) had 2 tests, 51 patients (10%) had 3 tests, 24 patients (5%) had 4 tests, 22 patients (4%) had 5 tests, 8 patients (2%) had 6 tests, 6 patients (1%) had 7 tests, 1 patient (0.2%) had 8 tests, and 2 patients (0.4%) had 9 tests.
Clinical response to stress
The clinical response to treadmill stress in the 499 patients at their initial exercise test is summarized in Table III . The obstructive group had significantly lower exercise capacity (METs) and was more likely to develop dyspnea and ST depression during exercise test. After adjusting for age and gender, the exercise capacity expressed as METs was still significantly lower in the obstructive group (adjusted difference −1.5, 95% CI −0.84 to −2.2, P b .001). The resting HR was similar in the 3 groups; however, the obstructive group had lower maximum HR and therefore lower HR response to exercise. Abnormal blood pressure response in patients younger than 50 years was more prevalent in the obstructive group compared with the nonobstructive and labile-obstructive groups.
Safety profile
For the safety profile, we evaluated all the exercise tests performed in our HCM cohort (n = 959). There were no deaths in this cohort during treadmill stress. Complications and arrhythmias during exercise are listed in Table IV . We observed no difference in complication rate between all the subgroups of patients with HCM. In Table V , patients are divided according to a resting gradient of 50 mm Hg to investigate the safety of this subset of patients with very high gradients, and there were no differences as well. We also compared the safety of exercise tests done on patients with prior myectomy (n = 106) or alcohol ablation (n = 17) and on patients managed on a strictly medical regimen (n = 836). The exercise tests performed on patients with prior septal reduction procedures account for both the patients (n = 14) who had procedures done before inclusion in our study and the patients who underwent septal reduction procedure during follow-up at our institution. We found no convincing difference between these groups. There was a significant difference in the prevalence of NSVT between the group treated with myectomy compared with the alcohol ablation group and the medically managed group (3.8% vs 0% vs 0.7%, P = .04); however, all the serious ventricular arrhythmias were seen in the medically treated group. In addition, no difference was seen in the combined safety end point.
The patients who had a safety event are described in detail in Table VI . A total of 20 events were noted corresponding to a total event rate of 2.1%, and the rate of ventricular arrhythmia was 1.4%. There were 3 incidents of potentially life-threatening arrhythmic events (overall rate of 0.3%). All patients recovered without complications; however, 1 patient required external defibrillation and 1 patient received a shock from his ICD. Two events, 1 case of VF and 1 case of VT, occurred in the nonobstructive group, and 1 case of VT occurred in the obstructive group (see Table VI ).
Utility of exercise test in high-gradient HCM
The utility of exercise testing was evaluated at the initial test in the cohort of 499 patients. Exercise testing provided an objective assessment of exercise capacity and symptoms in all patients with HCM. The relationship between New York Heart Association (NYHA) class and the METs achieved during exercise test is illustrated in Figure. It shows substantial overlap between the different NYHA classes, illustrating the inaccuracy of the clinical NYHA class evaluation. In addition, exercise testing gave information regarding risk stratification of SCD in a substantial number of patients with HCM. We could retrieve information about BP response in 97% of the patients with HCM, and we evaluated exercise-induced arrhythmias in all patients. In the entire cohort of patients with HCM, the initial exercise test gave information regarding SCD risk stratification in 95 patients (19%)-89 patients (age ≤50 years) developed ABPR and 6 patients had exerciseinduced ventricular arrhythmia. 6, 7 In patients with obstructive HCM, information regarding risk stratification was obtained in 31 patients (20%); 30 patients (age ≤50 years) developed ABPR and 1 patient had exerciseinduced ventricular arrhythmia.
Discussion
The main result of our study is that incidence of complications and life-threatening arrhythmias during exercise testing is low in patients with HCM. Likewise, subgroup analysis, with lower number of patients, indicates that exercising patients with high-gradient HCM poses no additional risk of adverse events. We find exercise testing to be capable of providing potentially important information in a substantial number (19%) of patients with high-gradient HCM. Patients with obstructive HCM had lower exercise capacity, higher incidence of ABPR, and ECG changes during exercise.
In our study, we evaluated differences in safety according to degree of LVOT obstruction, because it is traditionally presumed that exercising patients with high-gradient HCM bears a higher risk of adverse effects. In addition, previous studies have been unclear about the incremental information provided by exercise testing in patients with high-gradient HCM. 11 In our study, we found no increased risk of adverse events, when exercising patients with obstructive HCM. However, these results are based on a subset of the total exercise tests (LVOT gradients N30 mm Hg [n = 246] and LVOT gradients N50 mm Hg [n = 149]) and should therefore be interpreted with caution. In our study, we also found no increased risk, when exercising patients with prior septal reduction procedures. However, these results are based on a small number of tests (alcohol ablation n = 17, myectomy n = 106) and should be confirmed in larger studies. The overall incidence of ventricular arrhythmias and complications in our study is comparable with a previous study by Gimeno et al, 6 which found the overall incidence of VF to be 0.2% and the incidence of ventricular arrhythmias to be 2%. In addition, the overall rate of serious arrhythmias is comparable with several smaller studies by Drinko et al 19 (0.4%), Bunch et al 20 (1.2%), and Sadoul et al 14 (0.6%). The small discrepancies seen between these studies may arise because of coincidence and the small sample sizes. However, none of these studies have examined the risk of complications according to LVOT obstruction.
Despite the low rate of complications during exercise test in HCM, the risk of ventricular arrhythmias and complications is higher than the complication rate of 1:2,500 seen during exercise test in an unselected general population. 13 This warrants that any echocardiographic laboratory doing exercise testing in patients with HCM takes sufficient safety precautions regarding monitoring and availability of trained personnel.
Another aim of this study was to evaluate the utility of exercise testing in a group of patients with high-gradient HCM. We find exercise testing to be capable of giving accurate information about functional class and helpful in assessing prognosis and risk of SCD in a substantial number of patients. Clinical NYHA class evaluation is subjective and has substantial interobserver variability and a poor correlation with functional class calculated from exercise time. 21, 22 Accordingly, we found substantial variation in the METs achieved during exercise among patients who are evaluated to be in the same NYHA class 10 (8) 12 (8) 14 (12) 36 (9) .48 Significant ST depression, n (%)
25 (20) 32 (22) (see Figure) . Therefore, exercise testing of patients with obstructive HCM is reasonable, especially in cases where an accurate assessment of functional class is important, such as before invasive septal reduction therapy.
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The overall risk assessment of SCD in HCM and the subsequent selection of patients for defibrillator therapy can be difficult. 11 Traditionally, several exercise-related parameters such as ABPR and exercise-induced VT have been linked to increased risk of SCD in HCM. 6, 7, 14 Likewise, a new study from Desai et al 23 found exercise capacity to be a predictor of SCD in patients with HCM. All these parameters are also relevant in high-gradient HCM, and in our cohort of obstructive HCM, the exercise testing provided information useful in risk stratification in a substantial number of patients.
Clinical implications
Based on our results, we suggest that exercise testing with assessment of exercise capacity, exercise-induced gradients, exercise-induced arrhythmia, and BP response should be considered in the evaluation of all patients with HCM irrespective of gradients. In our study, although on a limited number of patients, the presence of LVOT obstruction was not associated with an increased risk of complications. Diligent electrocardiographic and hemodynamic monitoring and availability of trained critical care personnel during the test are mandatory, given the serious nature of the potential adverse events.
Limitations
The Johns Hopkins HCM Center is a tertiary referral center, and our cohort may not be reflective of or be extrapolated to the general population. Because of the relatively low number of complications during exercise testing and the rare nature of HCM, it is difficult to achieve statistical power to address the question about safety differences according to gradients. Hence, although this study is one of the largest studies regarding exercise testing in HCM, minor differences in complications might be missed. As in other database studies, we have missing data, and in our study, most variables have only 0% to 2% missing data; however, some variables have a slightly higher rate of missing data between 3% and 5%, and these are family history of HCM, interventricular diameters, and ABPR. These numbers are in accordance with the missing data in other retrospective studies. In our clinic, oxygen consumption test is not used routinely; however, these data could have provided a more accurate assessment of exercise capacity. When determining LVOT gradients, we used both direct measurements with continuous wave Doppler and supplemented with indirect calculations from MR jet velocity. The latter method has limitations in the assumption of left atrial pressure as 10 mm Hg, and especially after exercise where BP drop occurs, there can be uncertainty linked with this method.
Conclusion
Our study suggests that exercise testing in patients with HCM is associated with a low risk of adverse events. Furthermore, this study, although in a selected cohort and in a limited number of patients, indicates that exercise testing in high-gradient HCM poses no additional risk of complications and provides potential important information about symptoms, functional class, and SCD risk stratification. We therefore suggest that patients with 
Figure
Achieved METs according to NYHA class. Line represents median; box, 25th-75th percentile; whiskers, higher 75th + 1.5 * (25th-75th); lower 25th − 1.5 * (25th-75th); dots, outliers.
